1. 3001 Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project. (September 2015) Authors: Kerr, K.; Dafni, U.; Schulze, K.; Thunnissen, E.; Bubendorf, L.; Hager, H.; Gately, K.; Biernat, W.; Vliegen, L.; Hernandez Losa, J.; Marchetti, A.; Cheney, R.; Warth, A.; Speel, E.J.; Blackhall, F.; Molina, M.A.; Shames, D.S.; Peters, S.; Stahel, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3BA A phase II trial of erlotinib (E) and bevacizumab (B) in patients with advanced non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations with and without T790M mutation. The Spanish Lung Cancer Group (SLCG) and the European Thoracic Oncology Platform (ETOP) BELIEF trial. (September 2015) Authors: Stahel, R.A.; Dafni, U.; Gautschi, O.; Felip, E.; Curioni-Fontecedro, A.; Peters, S.; Massutí, B.; Cardenal, F.; Aix, S.P.; Früh, M.; Pless, M.; Popat, S.; Kotsakis, A.; Cuffe, S.; Bidoli, P.; Favaretto, A.; Carcereny, E.; Sanchez Ronco, M.; Molina, M.A.; Rosell, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P030: Obstetric antiphospholipid syndrome: beyond the Sidney criteria. Issue 175 (March 2019) Authors: Ordoñez, J.; Georgiett, T.; Molina, M.A.; Ghione, S.; Hadad, M.R.; Del Val, L.A.; González, M.G. Journal: Thrombosis research Issue: Issue 175(2019)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗